ArticleCPT: pharmacometrics & systems pharmacology2022

Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug.

Alan Faraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.